Immunomedics (IMMU) Cash Flow Statement

Click line-items for a historical chart and %

Cash flows from operating activities:
Net (loss)	-16.23M
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Gain on insurance claim for equipment failure
Decrease in allowance for doubtful accounts
Amortization of discounts of auction rate securities
Gain on sale of auction rate securities
Non-cash expense relating to issuance of stock options
Non-cash increase in value of life insurance policy
Amortization of deferred rent	24.88K
Changes in other operating assets and liabilities
Other
Net cash used in operating activities
Cash flows from investing activities:
Proceeds from sales of auction rate securities
Purchases of property and equipment	-647.57K
Proceeds from insurance claim for equipment failure
Net cash (used in) provided by investing activities
Cash flows from financing activities:
Exercise of stock options, net	105.13K
Net cash provided by financing activities
Net decrease in cash and cash equivalents	-4.74M
Cash and cash equivalents, beginning of period	13.2M
Cash and cash equivalents, end of period	8.46M

Entities mentioned with IMMU